IAMA Therapeutics is a pharmaceutical business that develops novel therapeutics for unmet medical needs in the brain.
Iama Therapeutics has raised $17.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Iama Therapeutics's investors include CDP Venture Capital, Indaco Venture Partners, Claris Ventures, CDP Equity, ENEA Tech e Biomedical.
Iama Therapeutics is headquartered in Genoa, Italy.
IAMA Therapeutics is a pharmaceutical business that develops novel therapeutics for unmet medical needs in the brain.
Iama Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iama Therapeutics — Funding & Investors." VCBacked, April 16, 2025, https://www.vcbacked.co/company/iama-therapeutics. Accessed July 20, 2026.
VCBacked. (2025). Iama Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/iama-therapeutics
{{cite web |title=Iama Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/iama-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated